Literature DB >> 18423814

Obesity-related glomerulopathy in China: a case series of 90 patients.

Hui-Mei Chen1, Shi-Jun Li, Hui-Ping Chen, Qing-Wen Wang, Lei-Shi Li, Zhi-Hong Liu.   

Abstract

BACKGROUND: The epidemic of obesity has been paralleled by an increase in the incidence of chronic kidney disease. However, epidemiological data for obesity-related glomerulopathy (ORG) from developing countries, including China, are very limited. STUDY
DESIGN: Case series. ORG defined as body mass index (BMI) of 28.0 kg/m(2) or greater; urinary protein excretion of 0.4 g/24 h or greater, and glomerulomegaly (glomerular volume > 3.27 x 10(6) microm(3)) with or without focal segmental glomerulosclerosis (FSGS). SETTING & PARTICIPANTS: 10,093 renal biopsy samples from patients obtained from February 2002 to November 2006 at the Research Institute of Nephrology, Nanjing University School of Medicine, China. PREDICTOR: Obesity defined as a BMI of 28.0 kg/m(2) or greater. Subjects were divided into 3 groups: mild-obesity group with BMI of 28.0 to less than 30 kg/m(2), moderate-obesity group with BMI of 30 to less than 35 kg/m(2), and severe-obesity group with BMI of 35 kg/m(2) or greater. OUTCOMES & MEASUREMENTS: Clinicoepidemiological and histopathologic characteristics of patients with ORG at the time of biopsy were described separately.
RESULTS: ORG was observed in 90 biopsy specimens (0.89%); frequency increased from 0.62% to 1.0% during the last 5 years (P = 0.02). Mean age was 37.5 +/- 9.3 (SD) years, 67% were men, mean BMI was 31.2 +/- 3.3 kg/m(2), waist circumference was 103 cm (range, 89.4 to 124 cm) in men and 96.5 cm (range, 88.5 to 113 cm) in women, waist-hip ratio was 0.95 +/- 0.07, and 100% had visceral obesity. Of the total, 49%, 37%, and 14% had mild, moderate, and severe obesity, respectively. Mean urinary protein excretion of subjects was 1.48 +/- 1.2 g/24 h; 51%, 39%, and 10% had proteinuria with protein of 0.4 to 1.0, 1.0 to 3.5, and greater than 3.5 g/d, respectively. Mean measured creatinine clearance (Ccr) was 109 +/- 32.2 mL/min/1.73 m(2), with 42%, 36%, and 22% with a Ccr greater than 120, 90 to 120, and less than 90 mL/min/1.73 m(2), respectively. Glucose dysmetabolism, insulin resistance, dyslipidemia, and hypertension were observed in 77%, 88%, 76%, and 63% of patients, respectively. FSGS was observed in 70%. Mean foot-process width was 534 +/- 176 nm. Foot-process fusion was seen in 36% of patients. Greater BMI was associated with greater proteinuria (P < 0.02), greater Ccr (P < 0.03), and greater foot-process width (P < 0.04). LIMITATIONS: Inability to compute prevalence or incidence from case series. BMI was calculated at time of renal biopsy.
CONCLUSIONS: Most patients with ORG had mild obesity, visceral obesity, minor proteinuria, preserved Ccr, and FSGS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423814     DOI: 10.1053/j.ajkd.2008.02.303

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  34 in total

1.  Estimating individual glomerular volume in the human kidney: clinical perspectives.

Authors:  Victor G Puelles; Monika A Zimanyi; Terence Samuel; Michael D Hughson; Rebecca N Douglas-Denton; John F Bertram; James A Armitage
Journal:  Nephrol Dial Transplant       Date:  2011-10-09       Impact factor: 5.992

2.  Mast cell infiltration and obesity-related glomerulopathy: an under-recognized disease process and new ways to approach treatment.

Authors:  Mihran Naljayan; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

Review 3.  The role of obesity in kidney disease: recent findings and potential mechanisms.

Authors:  Rigas G Kalaitzidis; Kostas C Siamopoulos
Journal:  Int Urol Nephrol       Date:  2011-05-05       Impact factor: 2.370

4.  Obesity-related glomerulopathy: body mass index and proteinuria.

Authors:  Wen-wen Shen; Hui-mei Chen; Hao Chen; Feng Xu; Lei-shi Li; Zhi-hong Liu
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

5.  Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease.

Authors:  Kosaku Nitta
Journal:  Cardiol Res Pract       Date:  2010-10-07       Impact factor: 1.866

6.  Evaluation of renal function and proteinuria based on mass health examinations in young Japanese obese adults.

Authors:  Kei Matsushita; Gen Yasuda; Masataka Shouda; Satoshi Umemura
Journal:  Clin Exp Nephrol       Date:  2009-04-18       Impact factor: 2.801

Review 7.  The role of obesity in the pathogenesis of hypertension.

Authors:  Yolanda E Bogaert; Stuart Linas
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-23

8.  Body mass index in 1.2 million adolescents and risk for end-stage renal disease.

Authors:  Asaf Vivante; Eliezer Golan; Dorit Tzur; Adi Leiba; Amir Tirosh; Karl Skorecki; Ronit Calderon-Margalit
Journal:  Arch Intern Med       Date:  2012-11-26

Review 9.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

Review 10.  Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease.

Authors:  Giorgina B Piccoli; Giorgio Grassi; Gianfranca Cabiddu; Marta Nazha; Simona Roggero; Irene Capizzi; Agostino De Pascale; Adriano M Priola; Cristina Di Vico; Stefania Maxia; Valentina Loi; Anna M Asunis; Antonello Pani; Andrea Veltri
Journal:  Rev Diabet Stud       Date:  2015-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.